Axonics to Participate in Upcoming Investor Conferences
25 April 2023 - 8:00PM
Business Wire
Axonics, Inc. (Nasdaq: AXNX), a global medical technology
company that is developing and commercializing novel products for
the treatment of bladder and bowel dysfunction, is scheduled to
participate in the following upcoming investor conferences:
Event: BofA Securities Healthcare Conference Date: Tuesday, May
9 Time: 2:20 p.m. Eastern Time
Event: RBC Capital Markets Healthcare Conference Date: Tuesday,
May 16 Time: 4:05 p.m. Eastern Time
Interested parties may access a live webcast and replay of each
presentation by visiting the Axonics investor relations
website.
About Axonics
Axonics is a global medical technology company that is
developing and commercializing novel products for adults with
bladder and bowel dysfunction. Axonics recently ranked No. 2 on the
2023 Financial Times ranking of the fastest growing companies in
the Americas and No. 4 on the 2022 Deloitte Technology Fast
500.
Axonics® sacral neuromodulation systems provide adults with
overactive bladder and/or fecal incontinence with long-lived, easy
to use, safe, clinically effective therapy. In addition, the
company’s best-in-class urethral bulking hydrogel, Bulkamid®,
provides safe and durable symptom relief to women with stress
urinary incontinence. In the U.S., moderate to severe urinary
incontinence affects an estimated 28 million women and fecal
incontinence affects an estimated 19 million adults. Axonics’
clinically proven products are offered at hundreds of medical
centers across the U.S. and abroad. Reimbursement coverage is well
established in the U.S. and is a covered service in most European
countries. For more information, visit www.axonics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230425005084/en/
Axonics contact: Neil Bhalodkar 949-336-5293
IR@axonics.com
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From Apr 2023 to Apr 2024